BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sheen IS, Jeng KS, Wu JY. Is p53 gene mutation an indicatior of the biological behaviors of recurrence of hepatocellular carcinoma? World J Gastroenterol 2003; 9(6): 1202-1207 [PMID: 12800224 DOI: 10.3748/wjg.v9.i6.1202]
URL: https://www.wjgnet.com/1007-9327/full/v9/i6/1202.htm
Number Citing Articles
1
Xinguo Chen, Jing Xu, Peixiao Wang, Lei Shang, Jing Guo, Lihong Huang, Yide A. Jiang, Jinhong Chen, Huijuan Chen, Yukui Shang, Qing Zhang. Metallophosphoesterase 1, a novel candidate gene in hepatocellular carcinoma malignancy and recurrenceCancer Biology & Therapy 2020; 21(11): 1005 doi: 10.1080/15384047.2020.1824480
2
Ashish Singhal, Muralidharan Jayaraman, Danny N. Dhanasekaran, Vivek Kohli. Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrenceCritical Reviews in Oncology/Hematology 2012; 82(2): 116 doi: 10.1016/j.critrevonc.2011.05.005
3
Shugo Suzuki, Pornsiri Pitchakarn, Kumiko Ogawa, Aya Naiki-Ito, Teera Chewonarin, Wanisa Punfa, Makoto Asamoto, Tomoyuki Shirai, Satoru Takahashi. Expression of glutathione peroxidase 2 is associated with not only early hepatocarcinogenesis but also late stage metastasisToxicology 2013; 311(3): 115 doi: 10.1016/j.tox.2013.07.005
4
Ray-Hwang Yuan, Yung-Ming Jeng, Hung-Wei Pan, Fu-Chang Hu, Po-Lin Lai, Po-Huang Lee, Hey-Chi Hsu. Overexpression of KIAA0101 Predicts High Stage, Early Tumor Recurrence, and Poor Prognosis of Hepatocellular CarcinomaClinical Cancer Research 2007; 13(18): 5368 doi: 10.1158/1078-0432.CCR-07-1113
5
César López-Camarillo, Elena Aréchaga Ocampo, Mavil López Casamichana, Carlos Pérez-Plasencia, Elizbeth Álvarez-Sánchez, Laurence A. Marchat. Protein Kinases and Transcription Factors Activation in Response to UV-Radiation of Skin: Implications for CarcinogenesisInternational Journal of Molecular Sciences 2011; 13(1): 142 doi: 10.3390/ijms13010142
6
Subramaniam Mohana Devi, Vellingiri Balachandar, Meyyazhagan Arun, Shanmugam Suresh Kumar, Balasubramanian Balamurali Krishnan, Keshavarao Sasikala. Analysis of Genetic Damage and Gene Polymorphism in Hepatocellular Carcinoma (HCC) Patients in a South Indian PopulationDigestive Diseases and Sciences 2013; 58(3): 759 doi: 10.1007/s10620-012-2409-8
7
R‐H Yuan, Y‐M Jeng, H‐L Chen, P‐L Lai, H‐W Pan, F‐J Hsieh, C‐Y Lin, P‐H Lee, H‐C Hsu. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinomaThe Journal of Pathology 2006; 209(4): 549 doi: 10.1002/path.2011
8
Kenji Yorita, Akinobu Ohno, Hiroaki Kataoka. Emerging histopathological prognostic biomarkers in hepatocellular carcinomasPersonalized Medicine Universe 2014; 3: 15 doi: 10.1016/j.pmu.2014.03.006
9
Richard A. Burkhart, Sean M. Ronnekleiv-Kelly, Timothy M. Pawlik. Personalized therapy in hepatocellular carcinoma: Molecular markers of prognosis and therapeutic responseSurgical Oncology 2017; 26(2): 138 doi: 10.1016/j.suronc.2017.01.009
10
M Guido, T Roskams, P Pontisso, M Fassan, S N Thung, L Giacomelli, A Sergio, F Farinati, U Cillo, M Rugge. Squamous cell carcinoma antigen in human liver carcinogenesisJournal of Clinical Pathology 2008; 61(4): 445 doi: 10.1136/jcp.2007.051383
11
S. GIANNI, A. CECCHETTO, G. ALTAVILLA, R. RAGAZZI, M. BERTAZZO, M. DE GIORGIO, A. BALDAN, S. FAGIUOLI, F. FARINATI. Tumour staging, morphology and p53 overexpression concur in predicting survival in hepatocellular carcinomaJournal of Internal Medicine 2005; 257(4): 367 doi: 10.1111/j.1365-2796.2005.01460.x
12
Gihan Hosny, Nahla Farahat, Hanan Tayel, Pierre Hainaut. Ser-249 TP53 and CTNNB1 mutations in circulating free DNA of Egyptian patients with hepatocellular carcinoma versus chronic liver diseasesCancer Letters 2008; 264(2): 201 doi: 10.1016/j.canlet.2008.01.031
13
Surong Hu, Lianying Zhao, Jingting Yang, Miao Hu. The association between polymorphism of P53 Codon72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3,704 casesTumor Biology 2014; 35(4): 3647 doi: 10.1007/s13277-013-1483-7
14
Yoon Jun Kim, Hyo-Suk Lee. Genetic epidemiological study on single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic HBV infectionThe Korean Journal of Hepatology 2009; 15(1): 7 doi: 10.3350/kjhep.2009.15.1.7
15
D.S.R. Lockwood, D.C. Gotley. Integration/Interaction of Oncologic GrowthCancer Growth and Progression 2005; 15: 165 doi: 10.1007/1-4020-3414-8_9
16
Xiao-Jia Yu, Fang Fang, Chun-Lei Tang, Lei Yao, Lu Yu, Long Yu. dbHCCvar: A comprehensive database of human genetic variations in hepatocellular carcinomaHuman Mutation 2011; 32(12): E2308 doi: 10.1002/humu.21595
17
Meng-Sen Li, Ping-Feng Li, Qian Chen, Guo-Guang Du, Gang Li. Alpha-fetoprotein stimulated the expression of some oncogenes in human hepatocellular carcinoma Bel 7402 cellsWorld Journal of Gastroenterology 2004; 10(6): 819-824 doi: 10.3748/wjg.v10.i6.819
18
Zhen Zhang, Hanyu Jiang, Jie Chen, Yi Wei, Likun Cao, Zheng Ye, Xin Li, Ling Ma, Bin Song. Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence predictionCancer Imaging 2019; 19(1) doi: 10.1186/s40644-019-0209-5
19
Christopher D. Mann, Christopher P. Neal, Giuseppe Garcea, Margaret M. Manson, Ashley R. Dennison, David P. Berry. Prognostic molecular markers in hepatocellular carcinoma: A systematic reviewEuropean Journal of Cancer 2007; 43(6): 979 doi: 10.1016/j.ejca.2007.01.004
20
Mia Kumar, Xuelian Zhao, Xin Wei Wang. Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine?Cell & Bioscience 2011; 1(1) doi: 10.1186/2045-3701-1-5
21
Matlola Bopape, Charlette Tiloke, Claudia Ntsapi. Moringa oleifera and Autophagy: Evidence from In Vitro Studies on Chaperone-Mediated Autophagy in HepG 2 Cancer Cells Nutrition and Cancer 2023; 75(10): 1822 doi: 10.1080/01635581.2023.2270215
22
Min Luo, Fan Yang, Sheng-xin Huang, Zhi-peng Kuang, Xiao-ling Luo, Yuan-dong Li, Ji-ning Wu, Yu-an Xie. Two-Stage Model of Chemically Induced Hepatocellular Carcinoma in MouseOncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2012; 20(11): 517 doi: 10.3727/096504013X13747716581336